These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
194 related articles for article (PubMed ID: 20228278)
21. Development of a fluorescent intensity assay amenable for high-throughput screening for determining 15-lipoxygenase activity. Dahlström M; Forsström D; Johannesson M; Huque-Andersson Y; Björk M; Silfverplatz E; Sanin A; Schaal W; Pelcman B; Forsell PK J Biomol Screen; 2010 Jul; 15(6):671-9. PubMed ID: 20581078 [TBL] [Abstract][Full Text] [Related]
22. Case studies of minimizing nonspecific inhibitors in HTS campaigns that use assay-ready plates. Liu Y; Beresini MH; Johnson A; Mintzer R; Shah K; Clark K; Schmidt S; Lewis C; Liimatta M; Elliott LO; Gustafson A; Heise CE J Biomol Screen; 2012 Feb; 17(2):225-36. PubMed ID: 21940710 [TBL] [Abstract][Full Text] [Related]
23. A high-throughput, homogeneous, fluorescence resonance energy transfer-based assay for phospho-N-acetylmuramoyl-pentapeptide translocase (MraY). Shapiro AB; Jahić H; Gao N; Hajec L; Rivin O J Biomol Screen; 2012 Jun; 17(5):662-72. PubMed ID: 22337656 [TBL] [Abstract][Full Text] [Related]
24. Mass spectrometric techniques for label-free high-throughput screening in drug discovery. Roddy TP; Horvath CR; Stout SJ; Kenney KL; Ho PI; Zhang JH; Vickers C; Kaushik V; Hubbard B; Wang YK Anal Chem; 2007 Nov; 79(21):8207-13. PubMed ID: 17902631 [TBL] [Abstract][Full Text] [Related]
25. A bioluminogenic HDAC activity assay: validation and screening. Halley F; Reinshagen J; Ellinger B; Wolf M; Niles AL; Evans NJ; Kirkland TA; Wagner JM; Jung M; Gribbon P; Gul S J Biomol Screen; 2011 Dec; 16(10):1227-35. PubMed ID: 21832257 [TBL] [Abstract][Full Text] [Related]
26. A bioluminescent method for measuring thymidylate kinase activity suitable for high-throughput screening of inhibitor. Hu CM; Chang ZF Anal Biochem; 2010 Mar; 398(2):269-71. PubMed ID: 19995545 [TBL] [Abstract][Full Text] [Related]
27. High-throughput discovery of Mycobacterium tuberculosis protein tyrosine phosphatase B (MptpB) inhibitors using click chemistry. Tan LP; Wu H; Yang PY; Kalesh KA; Zhang X; Hu M; Srinivasan R; Yao SQ Org Lett; 2009 Nov; 11(22):5102-5. PubMed ID: 19852491 [TBL] [Abstract][Full Text] [Related]
28. Development of a high-throughput fluorescence polarization DNA cleavage assay for the identification of FEN1 inhibitors. McWhirter C; Tonge M; Plant H; Hardern I; Nissink W; Durant ST J Biomol Screen; 2013 Jun; 18(5):567-75. PubMed ID: 23427045 [TBL] [Abstract][Full Text] [Related]
29. Target immobilization as a strategy for NMR-based fragment screening: comparison of TINS, STD, and SPR for fragment hit identification. Kobayashi M; Retra K; Figaroa F; Hollander JG; Ab E; Heetebrij RJ; Irth H; Siegal G J Biomol Screen; 2010 Sep; 15(8):978-89. PubMed ID: 20817886 [TBL] [Abstract][Full Text] [Related]
30. Streamlined system for purifying and quantifying a diverse library of compounds and the effect of compound concentration measurements on the accurate interpretation of biological assay results. Popa-Burke IG; Issakova O; Arroway JD; Bernasconi P; Chen M; Coudurier L; Galasinski S; Jadhav AP; Janzen WP; Lagasca D; Liu D; Lewis RS; Mohney RP; Sepetov N; Sparkman DA; Hodge CN Anal Chem; 2004 Dec; 76(24):7278-87. PubMed ID: 15595870 [TBL] [Abstract][Full Text] [Related]
32. High-throughput screening of kinase inhibitors by multiplex capillary electrophoresis with UV absorption detection. He Y; Yeung ES Electrophoresis; 2003 Jan; 24(1-2):101-8. PubMed ID: 12652579 [TBL] [Abstract][Full Text] [Related]
33. Use of a real-time fluorescence monitoring system for high-throughput screening for prolyl isomerase inhibitors. Mori T; Itami S; Yanagi T; Tatara Y; Takamiya M; Uchida T J Biomol Screen; 2009 Apr; 14(4):419-24. PubMed ID: 19403925 [TBL] [Abstract][Full Text] [Related]
34. Defining balanced conditions for inhibitor screening assays that target bisubstrate enzymes. Yang J; Copeland RA; Lai Z J Biomol Screen; 2009 Feb; 14(2):111-20. PubMed ID: 19196704 [TBL] [Abstract][Full Text] [Related]
35. A high throughput metabolic stability screening workflow with automated assessment of data quality in pharmaceutical industry. Xu R; Manuel M; Cramlett J; Kassel DB J Chromatogr A; 2010 Mar; 1217(10):1616-25. PubMed ID: 20132940 [TBL] [Abstract][Full Text] [Related]
36. [High-throughput screening of human soluble epoxide hydrolase inhibitors]. Wang SB; Guo J; Yu XM; Du GH Yao Xue Xue Bao; 2010 Nov; 45(11):1367-72. PubMed ID: 21361036 [TBL] [Abstract][Full Text] [Related]
37. [High-throughput screening of human soluble protein tyrosine phosphatase 1B inhibitors]. Pang XB; Xie XM; Wang SB; Du GH Yao Xue Xue Bao; 2011 Sep; 46(9):1058-64. PubMed ID: 22121775 [TBL] [Abstract][Full Text] [Related]
38. Characterization of binding properties of monoglyceride lipase inhibitors by a versatile fluorescence-based technique. Savinainen JR; Yoshino M; Minkkilä A; Nevalainen T; Laitinen JT Anal Biochem; 2010 Apr; 399(1):132-4. PubMed ID: 20005861 [TBL] [Abstract][Full Text] [Related]
39. Acetylcholinesterase immobilized capillary reactors-tandem mass spectrometry: an on-flow tool for ligand screening. Vanzolini KL; Vieira LC; Corrêa AG; Cardoso CL; Cass QB J Med Chem; 2013 Mar; 56(5):2038-44. PubMed ID: 23330848 [TBL] [Abstract][Full Text] [Related]